Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...

Researchers have calibrated an AI algorithm to more specifically identify patients with hypertrophic cardiomyopathy (HCM), a ...

Mount Sinai's AI-powered ECG tool now predicts individual risk for hypertrophic cardiomyopathy (HCM), enabling faster ...

A team of US researchers, studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) said they have ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...

The Viz HCM algorithm, calibrated by Mount Sinai, improves identification of hypertrophic cardiomyopathy patients, ensuring timely and personalized treatment.

Phase 2 trial of EDG-7500 demonstrated rapid and clinically meaningful reductions in LVOT gradients in participants with obstructive HCM – – Four-week treatment with EDG-7500 demonstrated ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI ...

More information: Calibration of ECG-Based Deep Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy, NEJM AI (2025). Provided by The Mount Sinai Hospital ...